Gilead Stocks jump on FDA Acceptance of remdesivir

Stocks of Gilead gained 6.3percent in pre-market trading Friday. Officials estimate that remdesivir will get earnings of about $ 2.17 billion annually, based on 13 surveyed by Bloomberg. Regulators had given an emergency-use approval for remdesivir before this season, and since the medication has come to be a popular treatment in hospitalized Covid-19 patients. It […]